Article
[Relationship between EGFR Mutations and Pathological Classification and Specimen of Lung Adenocarcinoma].
Zhongguo fei ai za zhi = Chinese journal of lung cancer - 20 Jun 2017
Kang Lifei, Zheng Jie, Zhu Xiang
Abstract excerpt
BACKGROUND: With the development of genetic mutations and targeted drugs, accurate therapy of lung adenocarcinoma attracts much more attention, and more research is focued on epidermal growth factor receptor (EGFR). It is unclear whether the result of EGFR mutation and pathology type is consistent with different specimens. In our study, by comparing the relationship between EGFR mutations and pathological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
